Suppressive Influences in the Immune Response to CancerBRONTE, Vincenzo; MOCELLIN, Simone.Journal of immunotherapy (1997). 2009, Vol 32, Num 1, pp 1-11, issn 1524-9557, 11 p.Article

Control of immune response by amino acid metabolismGROHMANN, Ursula; BRONTE, Vincenzo.Immunological reviews. 2010, Vol 236, pp 243-264, issn 0105-2896, 22 p.Article

Tumor-induced immune dysfunctions caused by myeloid suppressor cellsBRONTE, Vincenzo; SERAFINI, Paolo; APOLLONI, Elisa et al.Journal of immunotherapy (1997). 2001, Vol 24, Num 6, pp 431-446, issn 1524-9557Article

Myeloid-derived suppressor cells exhibit two bioenergetic steady-states in vitroHAMMAMI, Ines; JINGKUI CHEN; BRONTE, Vincenzo et al.Journal of biotechnology. 2011, Vol 152, Num 1-2, pp 43-48, issn 0168-1656, 6 p.Article

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cellsMARIGO, Ilaria; DOLCETTI, Luigi; SERAFINI, Paolo et al.Immunological reviews. 2008, Vol 222, pp 162-179, issn 0105-2896, 18 p.Article

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cellsSERAFINI, Paolo; CARBLEY, Rebecca; NOONAN, Kimberly A et al.Cancer research (Baltimore). 2004, Vol 64, Num 17, pp 6337-6343, issn 0008-5472, 7 p.Article

Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical PerspectiveMONTERO, Alberto J; MARCELA DIAZ-MONTERO, Claudia; KYRIAKOPOULOS, Christos E et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 107-115, issn 1524-9557, 9 p.Article

Cancer immunotherapy based on killing of Salmonella-infected tumor cellsAVOGADRI, Francesca; MARTINOLI, Chiara; PETROVSKA, Liljana et al.Cancer research (Baltimore). 2005, Vol 65, Num 9, pp 3920-3927, issn 0008-5472, 8 p.Article

CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory responseSFONDRINI, Lucia; BESUSSO, Dario; BRONTE, Vincenzo et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 8, pp 697-704, issn 0340-7004, 8 p.Article

Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytesUGEL, Stefano; SCARSELLI, Elisa; MUSIANI, Piero et al.Blood. 2010, Vol 115, Num 7, pp 1374-1384, issn 0006-4971, 11 p.Article

Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor a usage by melanoma-specific CD8⁺ T lymphocytesDE PALMA, Raffaele; MARIGO, Maria; ZANOVELLO, Paola et al.Cancer research (Baltimore). 2004, Vol 64, Num 21, pp 8068-8076, issn 0008-5472, 9 p.Article

Antitumor vaccination : where we standBOCCHIA, Monica; BRONTE, Vincenzo; ZANON, Paola et al.Haematologica (Roma). 2000, Vol 85, Num 11, pp 1172-1206, issn 0390-6078Article

High-Avidity T Cells Are Preferentially Tolerized in the Tumor MicroenvironmentZIQIANG ZHU; SINGH, Vinod; WATKINS, Stephanie K et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 2, pp 595-604, issn 0008-5472, 10 p.Article

Derangement of immune responses by myeloid suppressor cellsSERAFINI, Paolo; DE SANTO, Carmela; MARIGO, Ilaria et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 2, pp 64-72, issn 0340-7004, 9 p.Article

Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2SANJEEV KUMAR MENDIRATTA; THAI, Gerald; ESLAHI, Nima K et al.Cancer research (Baltimore). 2001, Vol 61, Num 3, pp 859-863, issn 0008-5472Article

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cellsSOLITO, Samantha; FALISI, Erika; GARRETT-MAYER, Elizabeth et al.Blood. 2011, Vol 118, Num 8, pp 2254-2265, issn 0006-4971, 12 p.Article

Interferon-a counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancerPERSANO, Luca; MOSERLE, Lidia; STÜRZL, Michael et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 5, pp 851-860, issn 0143-3334, 10 p.Article

Tumor-specific Th17-polarized cells eradicate large established melanoma. CommentaryBRONTE, Vincenzo; MURANSKI, Pawel; PTAK, Krzysztof et al.Blood. 2008, Vol 112, Num 2, issn 0006-4971, 214, 362-373 [13 p.]Article

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150GHISI, Margherita; CORRADIN, Alberto; DE BELLIS, Gianluca et al.Blood. 2011, Vol 117, Num 26, pp 7053-7062, issn 0006-4971, 10 p.Article

Myeloid cell diversification and complexity: an old concept with new turns in oncologyCHIODA, Mariacristina; PERANZONI, Elisa; DESANTIS, Giacomo et al.Cancer metastasis reviews. 2011, Vol 30, Num 1, pp 27-43, issn 0167-7659, 17 p.Article

IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancerMARTINI, Matteo; TESTI, Maria Grazia; KRAMPERA, Mauro et al.Vaccine. 2010, Vol 28, Num 20, pp 3548-3557, issn 0264-410X, 10 p.Article

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. CommentaryVIVIER, Eric; DALOD, Marc; PERRUCCIO, Katia et al.Blood. 2006, Vol 107, Num 7, issn 0006-4971, 2591-2592,2846-2854 [11 p.]Article

Identification of a CD 11b⁺/Gr-1⁺/CD31⁺ myeloid progenitor capable of activating or suppressing CD8⁺ T cellsBRONTE, Vincenzo; APOLLONI, Elisa; CABRELLE, Anna et al.Blood. 2000, Vol 96, Num 12, pp 3838-3846, issn 0006-4971Article